You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Trastuzumab biosimilar HLX02

Showing 26 - 50 of 1,170
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients Trial (PERT-IJS plus trastuzumab,

Not yet recruiting
  • HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
  • PERT-IJS plus trastuzumab, carboplatin and docetaxel
  • Perjeta plus trastuzumab, carboplatin and docetaxel
  • (no location specified)
Sep 21, 2023

Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Changchun (Trastuzumab for injection, Herceptin)

Completed
  • Metastatic Breast Cancer
  • Metastatic Gastric Cancer
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Mar 1, 2023

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

HER2-directed Biosimilar in Breast Cancer: Real World ePRO

Recruiting
  • HER2-positive Breast Cancer
  • +2 more
    • Horgen, Zurich, Switzerland
    • +4 more
    Oct 3, 2022

    Multiple Myeloma, Lymphoma, Engagement, Patient Trial (Grastofil®, Lapelga)

    Not yet recruiting
    • Multiple Myeloma
    • +3 more
    • (no location specified)
    Oct 30, 2023

    Metastatic Breast Cancer With a Isolated Brain Progression Trial in France (Tucatinib, Pertuzumab, Trastuzumab)

    Recruiting
    • Metastatic Breast Cancer With a Isolated Brain Progression
    • Angers, France
    • +33 more
    Aug 10, 2022

    Colon Adenocarcinoma, ERBB2 Gene Amplification, Rectal Adenocarcinoma Trial in Puerto Rico, United States (biological, drug,

    Active, not recruiting
    • Colon Adenocarcinoma
    • +18 more
    • Cetuximab
    • +5 more
    • Anchorage, Alaska
    • +797 more
    Jan 9, 2023

    Breast Cancer Trial in Brazil

    Recruiting
    • Breast Cancer
      • Manaus, Amazonas, Brazil
      • +11 more
      May 28, 2021

      HER2-positive Breast Cancer, Metastatic Breast Cancer Trial in Seoul (Trastuzumab biosimilars(Herzuma), Gedatolisib)

      Unknown status
      • HER2-positive Breast Cancer
      • Metastatic Breast Cancer
      • Trastuzumab biosimilars(Herzuma), Gedatolisib
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Feb 16, 2021

      Hidradenitis Suppurativa Trial in Lahore (Infliximab biosimilar)

      Active, not recruiting
      • Hidradenitis Suppurativa
      • Infliximab biosimilar
      • Lahore, Punjab, Pakistan
        Services Institute of Medical Sciences
      Dec 22, 2022

      Pharmacokinetics, Pharmacodynamics Trial in Chula Vista (I004, NovoLog)

      Recruiting
      • Pharmacokinetics
      • Pharmacodynamics
      • Chula Vista, California
        Amphastar Study Site
      Sep 13, 2022

      Psoriasis Trial in Worldwide (Stelara, AVT04)

      Completed
      • Psoriasis
      • Tallinn, Estonia
      • +29 more
      Feb 1, 2023

      B-cell Non Hodgkin's Lymphoma Trial (HLX01, Rituximab)

      Completed
      • B-cell Non Hodgkin's Lymphoma
      • (no location specified)
      May 4, 2022

      Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)

      Not yet recruiting
      • Ovarian Cancer
      • Houston, Texas
        MD Anderson Cancer Center
      Oct 9, 2023

      Recurrent Brain Tumor Trial in Houston (biological, other, radiation)

      Active, not recruiting
      • Recurrent Brain Neoplasm
      • Bevacizumab
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 9, 2022

      Healthy Adult Subjects Trial in Christchurch (AVT05, Simponi)

      Recruiting
      • Healthy Adult Subjects
      • AVT05
      • Simponi
      • Christchurch, New Zealand
        New Zealand Clinical Research
      Jan 13, 2023

      Hepatocellular Carcinoma by BCLC Stage Trial in Guangzhou (Bevacizumab Biosimilar QL 1101)

      Not yet recruiting
      • Hepatocellular Carcinoma by BCLC Stage
      • Bevacizumab Biosimilar QL 1101
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      May 20, 2023

      Breast Cancer Trial in Saint Petersburg (BCD-178, Perjeta)

      Active, not recruiting
      • Breast Cancer
      • Saint Petersburg, Russian Federation
      • +1 more
      Feb 13, 2023

      Infertility Trial in Xi'an (Biosimilar cetrorelix acetate, Reference cetrorelix acetate)

      Not yet recruiting
      • Infertility
      • Biosimilar cetrorelix acetate
      • Reference cetrorelix acetate
      • Xi'an, None Selected, China
        He Cai
      Sep 7, 2023

      Hepatocellular Carcinoma Trial in Shanghai (HLX10 3mg/kg, HLX04 5mg/kg, HLX04 10mg/kg)

      Active, not recruiting
      • Hepatocellular Carcinoma
      • HLX10 3mg/kg
      • +2 more
      • Shanghai, China
        Ethics committee of zhongshan hospital affiliated to fudan unive
      Dec 30, 2021

      Breast Cancer Trial in Shanghai (Pegylated liposomal doxorubicin, Epirubicin, Cyclophosphamid)

      Recruiting
      • Breast Cancer
      • Pegylated liposomal doxorubicin
      • +5 more
      • Shanghai, China
        Shanghai Pudong Hospital
      Dec 11, 2022

      GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)

      Recruiting
      • GastroEsophageal Cancer
      • Gastric Cancer
      • Tampa, Florida
        Moffitt Cancer Center
      Oct 25, 2023

      Hepatocellular Carcinoma Trial in Guangzhou (Sintilimab)

      Recruiting
      • Hepatocellular Carcinoma
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Sep 4, 2023

      HER2-positive Breast Cancer Trial (Tucatinib (Combination of tucatinib-Oral VP16-trastuzumab))

      Not yet recruiting
      • HER2-positive Breast Cancer
      • Tucatinib (Combination of tucatinib-Oral VP16-trastuzumab)
      • (no location specified)
      Jul 20, 2023

      Pyrotinib Plus Trastuzumab Versus Pertuzumab Plus Trastuzumab

      Active, not recruiting
      • Breast Cancer
      • Pyrotinib Plus Trastuzumab
      • Pertuzumab Plus Trastuzumab
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Oct 5, 2022